Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use
CA 2350167 A1 · Owner: Fernandez-Alnemri, Teresa · Inventors: Fernandez-Alnemri, Teresa; Alnemri, Emad S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to an isolated nucleic acid molecule encoding a caspase- 14 polypeptide or functional fragment thereof a vector that contains the , nucleic acid molecule and a host cell that contains the vector. The invention also relates to an isolated gene encoding caspase-14 as well as functional , fragments thereof. The gene or nucleic acid molecule can include single or double stranded nucleic acids corresponding to coding or non-coding strands of the caspase-14 nucleotide sequence. Isolated caspase-14 polypeptides or functional fragments thereof are also provided as are antibodies that , specifically bind thereto. In addition the invention relates to methods of , identifying …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 29, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 29, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 29, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.